NEW YORK (GenomeWeb) – Biodesix said today it has entered a collaboration agreement with Chinese life sciences firm Bioyong Technology to develop and commercialize Biodesix's Veristrat test for clinical use in China.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.